Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nifedipine Market Research Report 2017

  • QYR1061032
  • 100 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the global Nifedipine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nifedipine in these regions, from 2012 to 2022 (forecast), covering

North America

Europe

China

Japan

Southeast Asia

India

Global Nifedipine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

Bayer

Actavis

Teva

Pfizer

Shyndec

Honglin

Huanghai

Yabao

Global Pharm

Huazhon

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Nifedipine Controlled Release Tablets

Nifedipine Extended Action Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nifedipine for each application, including

Primary Pulmonary Hypertension

Heart Failure

Raynaud’s Syndrome

Cephalagra

Bronchial Asthma

Table of Contents

Global Nifedipine Market Research Report 2017

1 Nifedipine Market Overview

1.1 Product Overview and Scope of Nifedipine

1.2 Nifedipine Segment by Type (Product Category)

1.2.1 Global Nifedipine Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)

1.2.2 Global Nifedipine Production Market Share by Type (Product Category) in 2016

1.2.3 Nifedipine Controlled Release Tablets

1.2.4 Nifedipine Extended Action Tablets

1.3 Global Nifedipine Segment by Application

1.3.1 Nifedipine Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Primary Pulmonary Hypertension

1.3.3 Heart Failure

1.3.4 Raynaud’s Syndrome

1.3.5 Cephalagra

1.3.6 Bronchial Asthma

1.4 Global Nifedipine Market by Region (2012-2022)

1.4.1 Global Nifedipine Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Nifedipine (2012-2022)

1.5.1 Global Nifedipine Revenue Status and Outlook (2012-2022)

1.5.2 Global Nifedipine Capacity, Production Status and Outlook (2012-2022)

2 Global Nifedipine Market Competition by Manufacturers

2.1 Global Nifedipine Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Nifedipine Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Nifedipine Production and Share by Manufacturers (2012-2017)

2.2 Global Nifedipine Revenue and Share by Manufacturers (2012-2017)

2.3 Global Nifedipine Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Nifedipine Manufacturing Base Distribution, Sales Area and Product Type

2.5 Nifedipine Market Competitive Situation and Trends

2.5.1 Nifedipine Market Concentration Rate

2.5.2 Nifedipine Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Nifedipine Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Nifedipine Capacity and Market Share by Region (2012-2017)

3.2 Global Nifedipine Production and Market Share by Region (2012-2017)

3.3 Global Nifedipine Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Nifedipine Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Nifedipine Consumption by Region (2012-2017)

4.2 North America Nifedipine Production, Consumption, Export, Import (2012-2017)

4.3 Europe Nifedipine Production, Consumption, Export, Import (2012-2017)

4.4 China Nifedipine Production, Consumption, Export, Import (2012-2017)

4.5 Japan Nifedipine Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Nifedipine Production, Consumption, Export, Import (2012-2017)

4.7 India Nifedipine Production, Consumption, Export, Import (2012-2017)

5 Global Nifedipine Production, Revenue (Value), Price Trend by Type

5.1 Global Nifedipine Production and Market Share by Type (2012-2017)

5.2 Global Nifedipine Revenue and Market Share by Type (2012-2017)

5.3 Global Nifedipine Price by Type (2012-2017)

5.4 Global Nifedipine Production Growth by Type (2012-2017)

6 Global Nifedipine Market Analysis by Application

6.1 Global Nifedipine Consumption and Market Share by Application (2012-2017)

6.2 Global Nifedipine Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Nifedipine Manufacturers Profiles/Analysis

7.1 Bayer

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Nifedipine Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Bayer Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Actavis

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Nifedipine Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Actavis Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Teva

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Nifedipine Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Teva Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Pfizer

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Nifedipine Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Pfizer Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Shyndec

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Nifedipine Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Shyndec Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Honglin

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Nifedipine Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Honglin Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Huanghai

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Nifedipine Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Huanghai Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Yabao

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Nifedipine Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Yabao Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Global Pharm

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Nifedipine Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Global Pharm Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Huazhon

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Nifedipine Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Huazhon Nifedipine Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

8 Nifedipine Manufacturing Cost Analysis

8.1 Nifedipine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Nifedipine

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Nifedipine Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Nifedipine Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Nifedipine Market Forecast (2017-2022)

12.1 Global Nifedipine Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Nifedipine Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Nifedipine Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Nifedipine Price and Trend Forecast (2017-2022)

12.2 Global Nifedipine Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Nifedipine Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Nifedipine Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Nifedipine Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370